JWCA
AZN icon

J.W. Cole Advisors’s AstraZeneca AZN Stock Holding History

J.W. Cole Advisors’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.07M Hold
10,930
– – 0.04% 486
2026
Q1 		$2.16M Buy
10,930
+407
+4% +$78.5K 0.07% 233
2025
Q4 		$1.9M Buy
10,523
+352
+3% +$61.7K 0.05% 403
2025
Q3 		$1.56M Sell
10,171
-320
-3% -$48.4K 0.03% 553
2025
Q2 		$1.47M Buy
10,491
+332
+3% +$46.5K 0.03% 536
2025
Q1 		$1.49M Buy
10,159
+7,888
+347% +$1.14M 0.05% 401
2024
Q4 		$298K Sell
2,271
-482
-18% -$67.5K 0.01% 784
2024
Q3 		$429K Sell
2,753
-24
-0.9% -$3.87K 0.02% 652
2024
Q2 		$433K Sell
2,777
-309
-10% -$46.5K 0.02% 559
2024
Q1 		$418K Buy
3,086
+135
+5% +$17.9K 0.02% 582
2023
Q4 		$398K Sell
2,951
-5
-0.2% -$650 0.02% 552
2023
Q3 		$400K Buy
2,956
+461
+18% +$63K 0.03% 473
2023
Q2 		$357K Sell
2,495
-55
-2% -$8.09K 0.03% 524
2023
Q1 		$354K Sell
2,550
-2,270
-47% -$305K 0.03% 547
2022
Q4 		$654K Buy
4,820
+2,328
+93% +$292K 0.05% 346
2022
Q3 		$273K Buy
2,492
+519
+26% +$65.8K 0.02% 573
2022
Q2 		$261K Sell
1,973
-219
-10% -$28.7K 0.02% 590
2022
Q1 		$291K Sell
2,192
-7
-0.3% -$839 0.02% 632
2021
Q4 		$256K Buy
2,199
+214
+11% +$25.2K 0.02% 701
2021
Q3 		$238K Buy
1,985
+66
+3% +$7.68K 0.02% 407
2021
Q2 		$230K Buy
+1,919
New +$211K 0.02% 659
2021
Q1 		– Sell
-2,437
Closed -$244K – 670
2020
Q4 		$244K Sell
2,437
-10,254
-81% -$1.09M 0.03% 537
2020
Q3 		$1.39M Buy
+12,691
New +$1.41M 0.11% 202
2020
Q1 		– Sell
-2,469
Closed -$246K – 132
2019
Q4 		$246K Buy
+2,469
New +$232K 0.03% 468

Other funds holding AZN

RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
CDDEC
Caisse Des Depots Et Consignations Paris, France $5.91B AUM 35.65% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return
ZIC
ZWJ Investment Counsel Atlanta, Georgia $3.09B AUM 39.43% 1-Year Est. Return

J.W. Cole Advisors's AZN Position: Q2 2026 in Review

J.W. Cole Advisors held its AstraZeneca (AZN) position steady in Q2 2026 at 10,930 shares worth $2.07M. The position accounts for 0.04% of the portfolio, ranked #486.

J.W. Cole Advisors first reported a position in AZN in Q4 2019 and has held it in 24 quarters since. The position peaked at $2.16M in Q1 2026. 443 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

  • J.W. Cole Advisors held 10,930 shares of AstraZeneca worth $2.07M as of Q2 2026.
  • J.W. Cole Advisors left its AstraZeneca share count unchanged in Q2 2026.
  • AstraZeneca made up 0.04% of J.W. Cole Advisors's portfolio in Q2 2026, its #486 holding.
  • J.W. Cole Advisors first reported a position in AstraZeneca in Q4 2019 and has held it in 24 quarters since.
  • J.W. Cole Advisors's AstraZeneca position peaked at $2.16M in Q1 2026.
  • 443 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on J.W. Cole Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.